Clinical Significance of Promoter Hypermethylation of ERβ and RARβ2 in Tumor and Serum DNA in Indian Breast Cancer Patients
暂无分享,去创建一个
Anurag Srivastava | S. Mirza | R. Ralhan | R. Parshad | Ranju Ralhan | S. D. Gupta | Siddartha Datta Gupta | Rajinder Parshad | Sameer Mirza | Gayatri Sharma | A. Srivastava | G. Sharma
[1] J. Minna,et al. Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. , 2001, Journal of the National Cancer Institute.
[2] M. Widschwendter,et al. Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. , 2000, Journal of the National Cancer Institute.
[3] A. Thor,et al. Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas , 1996, Science.
[4] M. Widschwendter,et al. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. , 1997, Cancer research.
[5] V. Speirs,et al. Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer. , 2010, Cancer research.
[6] S. Mirza,et al. Prognostic Relevance of Promoter Hypermethylation of Multiple Genes in Breast Cancer Patients , 2009, Cellular oncology : the official journal of the International Society for Cellular Oncology.
[7] B. Shapiro,et al. Free DNA in the serum of cancer patients and the effect of therapy. , 1977, Cancer research.
[8] Xin Hu,et al. Correlation between CpG methylation profiles and hormone receptor status in breast cancers , 2007, Breast Cancer Research.
[9] G. Lazennec. ER Inhibits Proliferation and Invasion of Breast Cancer Cells , 2001 .
[10] V. Speirs,et al. Reduced expression of oestrogen receptor β in invasive breast cancer and its re‐expression using DNA methyl transferase inhibitors in a cell line model , 2003, The Journal of pathology.
[11] S. Mirza,et al. CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients. , 2010, Clinical biochemistry.
[12] J. Isola,et al. Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. , 2000, The American journal of pathology.
[13] A. Lazaris,et al. The favourable prognostic value of oestrogen receptor β immunohistochemical expression in breast cancer , 2004, Journal of Clinical Pathology.
[14] R. Gelber,et al. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] B. Iacopetta,et al. DNA hypermethylation in breast cancer and its association with clinicopathological features. , 2006, Cancer letters.
[16] Anurag Srivastava,et al. Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients. , 2010, Clinical biochemistry.
[17] W. Miller,et al. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk. , 2004, Molecular cancer research : MCR.
[18] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[19] V. Speirs,et al. Distinct expression patterns of ERα and ERβ in normal human mammary gland , 2002 .
[20] S. Mirza,et al. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. , 2010, Life sciences.
[21] A. Giuliano,et al. Distinct Hypermethylation Profile of Primary Breast Cancer Is Associated with Sentinel Lymph Node Metastasis , 2005, Clinical Cancer Research.
[22] J. Minna,et al. Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[23] Anthony Rhodes,et al. Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors: a comparative study involving results from laboratories in 21 countries. , 2002, American journal of clinical pathology.
[24] R. Laucirica,et al. Estrogen receptor beta expression in invasive breast cancer. , 2001, Human pathology.
[25] M. Kerin,et al. Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer? , 1999, Cancer research.
[26] Jorma Isola,et al. Estrogen Receptor β Is Coexpressed with ERα and PR and Associated with Nodal Status, Grade, and Proliferation Rate in Breast Cancer , 2000 .
[27] Peter A. Jones,et al. Epigenetics in cancer. , 2010, Carcinogenesis.
[28] R. Dahiya,et al. Cytosine-phosphoguanine methylation of estrogen receptors in endometrial cancer. , 2001, Cancer research.
[29] P. Cole,et al. Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms. , 2002, Cancer research.
[30] A. Lucas,et al. ERβ Inhibits Proliferation and Invasion of Breast Cancer Cells. , 2001, Endocrinology.
[31] Paul Cairns,et al. Tumor Suppressor Gene Promoter Hypermethylation in Serum of Breast Cancer Patients , 2004, Clinical Cancer Research.
[32] K. Dechering,et al. Estrogen receptors alpha and beta: two receptors of a kind? , 2000, Current medicinal chemistry.
[33] V. Speirs,et al. Distinct expression patterns of ER alpha and ER beta in normal human mammary gland. , 2002, Journal of clinical pathology.
[34] S. Mirza,et al. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. , 2007, Life sciences.
[35] L. E. McDonald,et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[36] S. Mader,et al. The N-terminal of the estrogen receptor (ERα) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells , 2003, The Journal of Steroid Biochemistry and Molecular Biology.
[37] L. Altucci,et al. Retinoids: potential in cancer prevention and therapy , 2004, Expert Reviews in Molecular Medicine.
[38] O. Ortmann,et al. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells , 2009, Breast Cancer Research and Treatment.
[39] J. Herman,et al. A gene hypermethylation profile of human cancer. , 2001, Cancer research.
[40] S. Sukumar,et al. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor β2 promoter in breast cancer cells , 2000, Oncogene.
[41] Chintamani,et al. Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India-A cross-sectional study , 2005, World journal of surgical oncology.
[42] Kornelia Polyak,et al. Very High Frequency of Hypermethylated Genes in Breast Cancer Metastasis to the Bone, Brain, and Lung , 2004, Clinical Cancer Research.
[43] A. Lucas,et al. ER beta inhibits proliferation and invasion of breast cancer cells. , 2001, Endocrinology.
[44] A. Jemal,et al. Global Cancer Statistics , 2011 .
[45] Valerie Speirs,et al. Coexpression of Estrogen Receptor α and β: Poor Prognostic Factors in Human Breast Cancer? , 1999 .